Proxy
ResMed designs, manufactures and distributes medical equipment for treating and diagnosing sleep disordered breathing.
Value
Total number of shares outstanding as of Jan. 19, 2000 14,900,000
Price of each share of common stock on Jan. 19, 2000 $45.875
Aggregate market value as of Jan. 19, 2000 $683,537,500.00
Performance Record
For year ended June 30, in thousands, except per-share data
1999 1998 1997
Net revenues $88,627 $66,519 $49,180
Net income (loss) $16,102 $10,611 $7,465
Net income (loss) per share $1.04 $0.71 $0.51
Total assets $89,889 $64,618 $54,895
Directors
Peter Farrell, 57, has been president and director since June 1989 and CEO since July 1990.
Christopher Roberts, 45, has been the executive vice president since August 1992. He has been a director since September 1992 and from August 1989 to November 1990.
Donagh McCarthy, 52, has been a director since November 1994. Since September 1996, he was president of RMS Inc., an affiliate of Baxter Healthcare.
Gary Pace, 51, has been director since July 1994. Since November 1994, he is the president and CEO of RTP Pharma Corp., a biopharmaceutical company.
Michael Quinn, 52, has been a director since September 1992 and a financial consultant since February 1992. He is also a director of Heggies Bulkhaul Ltd.
ResMed Inc.
NYSE RMD
Executive Compensation
Officers Cash Compensation
Peter Farrell, president and CEO $433,737
Christopher Roberts, executive vice president $219,395
Norman DeWitt, vice president of U.S. marketing $167,631
Walter Flicker, corporate secretary $123,726
Michael Hallett, vice president of new ventures $133,246
Significant Stock Ownership
Number of shares Percent
Sept. 9, 1999
William Blair & Co. LLC 1,726,000 11.60
Pilgrim Baxter and Associates, Ltd. 1,448,000 9.73
Peter Farrell 797,212 5.36
Directors and executive officers as a group (14 persons) 1,604,262 10.78
Other Information
Headquarters: 10121 Carroll Canyon Road, San Diego 92131-1109; (858) 689-2400; fax (858) 622-2043; (www.resmed.com)
Auditors: KPMG LLP, San Diego
Information was compiled from the company’s annual and proxy reports.
